Jiangsu Simcere Pharmaceutical Co., Ltd.

This first-in-human trial is testing an experimental triple-target antibody called SIM0500 in adults with multiple myeloma that has returned or stopped responding to all standard treatments. The study aims to find a safe dose and see early signs of whether the treatment can shrin…

This is the first study in humans testing a new drug called SIM0610 for people with advanced solid tumors that have spread or can't be removed by surgery. The trial will enroll 260 adults with cancers like lung, colorectal, liver, and head/neck cancer who have tried standard trea…

This study is testing whether a new drug called SIM0270, when combined with an existing medication (everolimus), works better than standard treatments for people with advanced breast cancer. It's for patients whose cancer has grown despite previous hormone therapy and a specific …

This is the first time a new drug called SIM0609 is being tested in people. The main goals are to find a safe dose and see how the body processes it. The study will also look for early signs that the drug might help shrink tumors in adults with advanced solid cancers who have no …

This study is testing whether adding a new drug called Suvemcitug to a standard chemotherapy pill works better than the pill alone for people with advanced colorectal cancer that has stopped responding to other treatments. About 464 participants will be randomly assigned to recei…

This early-stage study aims to understand how a new drug called SIM0270 interacts with other common medications in the body. Researchers will enroll 60 healthy Chinese adults to measure how SIM0270's levels in the blood change when taken with other drugs. The goal is to gather ba…